Skip to Main Content

Paper Details

The predictive value of partial promoter methylation for IDH-wild-type glioblastoma patients.
2
2023
93) promoters, Cancer, Glioblastoma, IDH, IDH-, IDH-wild, IDH-wildtype, NOS, O-methylguanine, O-methylguanine-methyltransferase () gene promoter, glioblastoma, isocitrate, isocitrate dehydrogenase, methylated, partially methylated promoters, patients, promoter, temozolomide
Author NameAffiliation
Patrick Y WenDana-Farber Cancer Institute and Harvard Medical School Boston
  • 1 - 1

Datasets

Release 1.2